Torrent Pharmaceuticals Limited (BOM: 500420)

Market Cap	1.07T
Revenue (ttm)	112.24B
Net Income (ttm)	18.02B
Shares Out	338.45M
EPS (ttm)	53.25
PE Ratio	59.44
Forward PE	44.87
Dividend	28.00 (0.88%)
Ex-Dividend Date	n/a

Volume	53,547
Average Volume	4,870
Open	3,172.15
Previous Close	3,179.70
Day's Range	3,152.60 - 3,193.70
52-Week Range	2,415.00 - 3,589.95
Beta	0.28
RSI	32.81
Earnings Date	Jan 27, 2025

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company...

• Industry: Pharmaceutical Preparations
• Founded: 1959
• Employees: 15,718
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500420

Financial Performance

In 2023, Torrent Pharmaceuticals's revenue was 107.28 billion, an increase of 11.51% compared to the previous year's 96.20 billion. Earnings were 16.56 billion, an increase of 33.02%.